Co-founded Alios BioPharma, Inc., and led the company from inception to acquisition by Johnson & Johnson.
Iain D. Dukes
Holds multiple Board/CEO positions, alongside world-class licensing experience including at Merck & Co. and Amgen Inc.
Managing Director, New Leaf Venture Partners
Founder of New Leaf Venture Partners with over 20 years investment and company-building experience.
Richard N. Kender
Involved in over 100 Business Development & Corporate Licensing transactions during 35 year tenure at Merck & Co.
Chau Q. Khuong
Private Equity Partner, OrbiMed
Experienced investor focused on structured investments across private and public biopharmaceutical and medical device companies.
Partner, Novo Holdings
Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).
Dr. Ken Powell
Founded and led Arrow Therapeutics Ltd to $150 million acquisition by AstraZeneca.
Alex C. Sapir
Chief Executive Officer
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Partner, Andera Partners
Top pedigree investments, IPOs and trade sales over 19 years with Andera Partners.